-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- Lineage Cell Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $38K, a 77.5% decline year-over-year.
- Lineage Cell Therapeutics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $436K, a 15.7% decline year-over-year.
- Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2023 was $671K, a 7.83% decline from 2022.
- Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2022 was $728K, a 48.9% decline from 2021.
- Lineage Cell Therapeutics, Inc. annual Cost of Revenue for 2021 was $1.43M, a 270% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)